1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
European Association of Nuclear Medicine Focus 5 : Consensus on Molecular Imaging and Theranostics in Prostate Cancer
(
- Contribution to journal › Article
- 2023
-
Mark
Cardiovascular Effects of GnRH Antagonists Compared With Agonists in Prostate Cancer : A Systematic Review
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer : Extended Analysis of the Phase 3 PREVAIL Study
(
- Contribution to journal › Article
- 2015
-
Mark
Achievements and Perspectives in Prostate Cancer Phase 3 Trials from Genitourinary Research Groups in Europe: Introducing the Prostate Cancer Consortium in Europe.
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Enzalutamide in metastatic prostate cancer before chemotherapy
(
- Contribution to journal › Article
-
Mark
Prevention and early detection of prostate cancer.
(
- Contribution to journal › Scientific review
- 2012
-
Mark
Testosterone in prostate cancer: the Bethesda consensus.
(
- Contribution to journal › Article
- 2011
-
Mark
Contemporary Role of Prostate Cancer Antigen 3 in the Management of Prostate Cancer
(
- Contribution to journal › Scientific review
- 2009
-
Mark
Castration-resistant Prostate Cancer: From New Pathophysiology to New Treatment Targets
(
- Contribution to journal › Article
- 2008
-
Mark
Management of advanced prostate cancer: can we improve on androgen deprivation therapy?
(
- Contribution to journal › Article